Cymbalta follow up

I’ve written previously about the launch and on-going marketing campaign for Cymbalta and the links that Lilly are keen to establish – recasting depression’s association with “vague aches and pains of varying degrees of severity” into a full blown campaign… which may or may not smack of off-label promotion.

Here’s some more on Cymbalta from the Independent:

Was Traci Johnson driven to suicide by anti-depressants? That’s a trade secret, say US officials…

Researchers trying to establish the truth about a new drug – now on sale in the UK – are being thwarted by a government agency whose job is to protect the public

By Jeanne Lenzer and Nicholas Pyke, published: 19 June 2005

When the body of a 19-year-old student, Traci Johnson, was found hanging from a shower rod in the laboratories of pharmaceuticals giant Eli Lilly, US officials were quick to announce that the death could not be linked to a new anti-depressant drug she was helping to test.

During her stay at the hotel-cum-clinic in Indiana known as the Lilly Lab, Johnson had been taking part in trials for a secret new formula called Cymbalta, a chemical cousin of Prozac, which the company hoped would guarantee huge profits for years to come.

Read the full article here.

One Response to “Cymbalta follow up”

  1. Matthew Holford Says:

    “US officials were quick to announce that the death could not be linked to a new anti-depressant drug she was helping to test.”

    I’ll bet it can.

    Matt


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: